Traveling Vineyard Saves Stay-At-Home Moms

Children are a beautiful gift that needs care and attention. Unfortunately, raising children requires a financial stability and being a mom is not a paying job. Rick Libby, the President of Traveling Vineyards, has found it possible to help out the moms who seem stranded with financial instability yet they can’t afford to go to work. The job comes with pretty interesting offers for being a wine guide.

Wine deals made include earning 15-35 percent commission on their total monthly sales. Even better, for bringing their friends on board to the company, there is a 100 dollars’ bonus when they achieve 750 dollars in their sales.

It does not require much if one learns how to manage their time well. When the product is popular in the market, it is easy to sell it. It is necessary to have a wide connection to people to ensure perfect working skills. Meeting new people is key since one can learn new tactics or acquire new clients. Networking with people from large organizations is better since one is more likely get enormous orders for parties and if the service is good one can get more bookings. Interesting to note, Traveling Vineyard is doing so much better compared to other wine selling companies.

About Napa Vineyard

The vineyard has a reputation for its outstanding wine quality. The vineyard is known for its popular production of grapes. It doesn’t focus entirely on wine as it hosts tourist too. It is an incredible view, and with the quality of the wine, everyone would consider an attractive site. Besides grapes, the soils suit olives very well, spices, flowers, and herbs.

Traveling Vineyard’s Profile

The company is located in Ipswich, Massachusetts and was founded in 2001. It has had around 5,000 representatives who have been trained and educated about wine and the best-selling strategies. Accessing Traveling Vineyards via their website is easy. The company has, of course, had its tough times in 2010 when the company was announced bankrupt. Richard could not give up on it and worked tirelessly to bring it back to its former glory. It now hosts wine tasting events. It is a warm organization where colleagues consider each other as family.

To know more visit @: www.travelingvineyard.com/host-wine-tasting-party/

The Oncotarget Success

Oncotarget is a peer-reviewed journal that focuses on the pathological basis of all cancer types, potential therapy targets as well as treatment protocols that are employed in order to enhance the management of individuals suffering from cancer. Oncotarget is also committed to the impact of new therapeutic agents, management programs and protocols on perspectives of patients such as adherence, life and also satisfaction. The medical journey which mostly focuses on Oncology also explores the evidence that is behind the existing and new therapies when it comes to enhancing outcomes. Oncotarget was launched in 2010 and is usually published by the Impact Journals.The Editors in Chief at Oncotarget are Mikhail Blagosklonny and Andrei Gudkov.

The two Editors in Chief also serve as scientists at the Roswell Park Cancer Institute. Oncotarget is a member of COPE (Committee on Publication Ethics) and also subscribes to the organization’s principles. The Journal Impact Factor of Oncotarget is currently 1.653 and is projected to be 2.612 by September 2017. Since its inception, the medical journal has managed to acquire a huge following which is international.  Oncotarget is normally abstracted also indexed in MEDLINE/PubMed, Science Citation Index Expanded, Scopus, Index Medicus and BIOSIS Previews. The rising popularity of Oncotarget has been attributed to its constructive, multiple peer-review, insightful and punctual approach.The medical journal has assisted its authors to enhance their research impact.

Following its success on oncology, Oncotarget has decided to now accept papers which are on topics other than oncology. The topics include Cell Biology, Endocrinology, Pharmacology and all its areas, Metabolism, Cardiology, Neuroscience and many others. Oncotarget as a term encompasses all cellular functions, pathways and molecules that are common in aging and cancer, microbes and cancer cells, neurons and lymphocytes as well as atherosclerosis and neurodegeneration. Oncotarget hopes to make results of science widely and rapidly available. It also seeks to make the impact maximum through its perceptive review.Through the leadership of prominent and skilled scientists, Oncotarget assists all scientific researchers in contributing to the science progress. The ultimate vision of the medical journal is to see people all over the world live a life without disease.

Talos Energy on the Gulf Coast

The Mexican government nationalized oil mining over 80 years ago and closed the oil and gas industry from private investment. The 1938 decision was reversed in an electoral vote back in 2012 to aid the ailing energy industry from the state-run monopoly of Petroleos Mexicanos. Immediately after, bids were made for companies and joint ventures to secure the right to explore the Zama-1 Well. A bid by three companies who intended to pursue the prospect as a joint venture sailed through. The three companies were;

Premier Oil Plc (based in London),

Talos Energy LLC (American and Houston-based),

And Mexican Sierra Oil and Gas.

The companies already had an agreement that described how they would split the costs and revenue shares. The Mexican company was entitled to 44 percent, the American company was entitled to 35 percent and the British company was entitled to 25 percent.

The commercial news world reacted boisterously to the new development of the lucrative oil prospecting contract on the Zama-1 Well. The Mexican government was also very firm in asserting that they would keenly follow the drilling to ensure that compliance would be upheld to protect the Mexican marine ecology. Such concerns were genuinely placed as the Zama-1 Well sits in the Sureste Basin. However, the fact that the oil well sits in the Sureste Basin also meant that the prospect had better geological chances of success because of the favorable structure of the basin.

The drilling expedition was estimated to take the three companies about 90 days to complete. According to tax reports, the joint venture had set aside over 16 million dollars for drilling alone. Talos energy and its partners estimate that the well holds about 200 to 500 barrels of crude oil.

Talos Energy LLC

Talos Energy is the winner of the 2013 WorkplaceDynamics’ Best Workplace among Local Small Businesses. It has always received praise from its main investor and regulator, Apollo Global Management, for having the most efficient and motivated employees in the American oil industry. It is a private company that focuses on prospecting for oil and acquiring oil properties in the Mexican Gulf and the Gulf Coast for exploitation. The company’s human resource department claims that it has an equity program where it allows its geologists and other specialist to share equity for any major oil discoveries that they make.

Facebook: https://www.facebook.com/talos.energy/

Clay Siegall follows dream, invents new class of cancer treatment drugs

Cancer treatment has traditionally entailed some of the most brutal regimes in medicine today. From radical surgery to radiation and chemotherapy, cancer treatment, since at least the 1930s, has been a torturous trial of endurance for any patient unlucky enough to receive a cancer diagnosis. Oftentimes, even the milder treatments, such as low dosage chemotherapies, will leave the patient with lasting deficits, such as neuropathy, dementia and other long-term neurological disorders.

However, there is a huge reward that has come with these terrible treatment. Cancer survival rates have increased dramatically over the last 70 years. Some cancers, which once were nearly always fatal, are now almost always curable, with five-year survival rates exceeding 99 percent. Prior to the 1930s, most diagnoses of cancer were tantamount to a death sentence. Few patients lived more than a couple of years.

Still, many types of cancer today do not have significantly better survival rates than they did 30 or 40 years ago. This is due largely to the fact that the three pillars of cancer treatment, surgery, radiation and chemotherapy essentially stopped getting better around the year 1960. While there have been certain improvements with some subtypes of cancer, many others have not seen any notable increases in survivability in the last 50 years.

But that began to change in the mid-1990s. Clay Siegall is one of the key players in developing the new class of drugs known as targeted cancer therapies. Most targeted therapies use the principle of targeting the malignancy directly, only releasing cytotoxic chemicals upon contact with the actual cancer cells. This reduces the worst side effects caused by chemotherapy, which is a medicinal blunt instrument, oftentimes releasing large amounts of poison directly into the bloodstream.

Aside from the near elimination of side effects, targeted cancer therapies are also able to dramatically increase the therapeutic window, allowing for much higher doses of cytotoxin and much more effective treatments.

Through his firm, Seattle Genetics, Dr. Siegall is continuing to develop this exciting new category of cancer treatment drugs, ensuring that the 21st century will see dramatic improvements in survivability of many subtypes of cancer.

OSI Industries Is A Simble Of American Success

OSI Industries opened its doors as a meat market in the early 1900s. It was founded by an immigrant named Otto Kolschowsky. Otto had a specific vision for his company. He named it Otto and Sons and proceeded to establish himself in the Chicago area. Over the years Otto adjusted his business model by providing service to food industries. This service included restaurants and supermarkets. Eventually Otto turned the business over to his sons and they continued the companies reputation of excellence.

As the 1950s approached, the McDonald’s Organization was expanding across the country. They were looking to establish themselves in Illinois and needed a meat supplier that they can trust. Otto and Sons was called upon to handle the task. Their relationship with the McDonald’s Organization blossomed over the years due to the many innovations that Otto and Sons brought to the meat manufacturing industry. They introduced cryogenic freezing chambers. This was a method of supplying large amounts of inventory without damaging it and delivering the product to McDonald’s in a workable fashion. Otto and Sons also introduced meat patty cutting machine, which catered to their most important client at the time.

Otto and Sons changed its name to OSI Industries and became the primary meat supplier to the McDonald’s Organization. OSI Industries expanded over the years to accommodate several other restaurant chains. Pizza Hut, Papa John’s Pizza, Starbucks and Subway are all clients of OSI Industries. The company has factories all over the world and operates with several different other food manufacturing companies. It allows OSI Industries to keep a diverse interest in food manufacturing, which helps them remain on cutting edge of industry.

OSI Industries acquired other companies such as Tyson Foods, Baho Foods and Flagship Food Group in order to expand its influence in a market that continues to grow.

To know more visit @: www.osigroup.com/capabilities/food-product-capabilities/